PRESS & MEDIA RESOURCES

LANSING, MI — Independent researcher and author Cat Clark is set to redefine the public conversation surrounding metabolic health with the release of her provocative new book, Fat Bitch: Killing the Willpower Myth. Arriving during a nationwide cultural reckoning with obesity medicine, the work establishes a definitive scientific framework for patients using GLP-1 receptor agonists (such as Wegovy, Zepbound, Ozempic, and Mounjaro) to bridge the gap between clinical intervention and long-term psychological recovery.

"The needle fixed the biology, but it didn't fix the shame," says Clark. "By unmasking the willpower myth, we allow patients to move past thirty years of societal gaslighting and understand the biological truth of their recovery. Obesity is a complex cellular signaling disorder, not a failure of moral character."

As the healthcare establishment pivots toward medicalized weight loss, Clark’s research addresses the psychological void left by traditional "eat less, move more" advice. The book serves as an unapologetic field manual for patients navigating insulin resistance, delayed gastric emptying, and healthcare provider bias.

LANSING, MI — Independent press UNLIT Publishing LLC announces the global launch of Fat Bitch: Killing the Willpower Myth by Lansing-based author Cat Clark. Marking the twenty-year anniversary of the 2005 cultural phenomenon Skinny Bitch, Clark’s book performs an evidence-based autopsy on the era that weaponized willpower and branded patients as "gluttonous pigs."

"Twenty years ago, diet culture told us that shame was a medical strategy. Twenty years later, the verdict is in: Shame failed," Clark states. "Fat Bitch arms patients with real science and tactical social boundary tools—like the Bean Dip Pivot—to navigate dinner-table interrogations with zero apologies."